ACM
FLNA

ADAR1 Capital Management’s Filana Therapeutics FLNA Stock Holding History

ADAR1 Capital Management’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-81,000
Closed -$236K – 294
2025
Q3 		$236K Buy
+81,000
New +$186K 0.02% 174

Other funds holding FLNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

ADAR1 Capital Management's FLNA Position: Q4 2025 in Review

ADAR1 Capital Management sold out of Filana Therapeutics (FLNA) in Q4 2025, closing a stake of 81,000 shares — an estimated $236K sold.

ADAR1 Capital Management first reported a position in FLNA in Q3 2025 and held it in 1 quarter. The position peaked at $236K in Q3 2025. 107 funds tracked by Wall St. Rank hold FLNA as of Q4 2025.

  • ADAR1 Capital Management reported no remaining Filana Therapeutics position as of Q4 2025 after selling out during the quarter.
  • ADAR1 Capital Management sold 81,000 Filana Therapeutics shares in Q4 2025, an estimated $236K.
  • ADAR1 Capital Management first reported a position in Filana Therapeutics in Q3 2025 and held it in 1 quarter.
  • ADAR1 Capital Management's Filana Therapeutics position peaked at $236K in Q3 2025.
  • 107 funds tracked by Wall St. Rank held Filana Therapeutics as of Q4 2025.

Based on ADAR1 Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.